Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
HempFlax Netherlands, a large cultivator and processor of industrial hemp, has announced plans to sell its extensive agricultural portfolio.
Romanian private healthcare group MedLife has completed the full acquisition of the Medstar group of clinics in Cluj-Napoca.
The initial public offering (IPO) of Electro-Alfa International kicked off on February 2nd and will end on 11th February 2026.
In 2024, 10.8% of the Romanian population was unable to keep their home adequately warm, according to the latest data released by Eurostat.
Romania's Ministry of Finance will launch the Fidelis II government bond programme from 6-13 February, offering tax-free interest rates of up to 7.25% for lei-denominated bonds and up to 6% for euro-denominated bonds.